DK1354873T3 - Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette - Google Patents

Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette

Info

Publication number
DK1354873T3
DK1354873T3 DK03290383T DK03290383T DK1354873T3 DK 1354873 T3 DK1354873 T3 DK 1354873T3 DK 03290383 T DK03290383 T DK 03290383T DK 03290383 T DK03290383 T DK 03290383T DK 1354873 T3 DK1354873 T3 DK 1354873T3
Authority
DK
Denmark
Prior art keywords
perindoapril
salt
pharmaceutical compositions
compositions containing
pharmaceutical
Prior art date
Application number
DK03290383T
Other languages
Danish (da)
English (en)
Inventor
Gerard Damien
Francois Lefoulon
Bernard Marchand
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8871521&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1354873(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Servier Lab filed Critical Servier Lab
Application granted granted Critical
Publication of DK1354873T3 publication Critical patent/DK1354873T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK03290383T 2002-04-18 2003-02-17 Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette DK1354873T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0204847A FR2838648B1 (fr) 2002-04-18 2002-04-18 Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent

Publications (1)

Publication Number Publication Date
DK1354873T3 true DK1354873T3 (da) 2004-11-01

Family

ID=8871521

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03290383T DK1354873T3 (da) 2002-04-18 2003-02-17 Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette

Country Status (38)

Country Link
US (1) US6696481B2 (pl)
EP (1) EP1354873B1 (pl)
JP (1) JP3737488B2 (pl)
KR (1) KR100542468B1 (pl)
CN (1) CN1211365C (pl)
AP (1) AP1787A (pl)
AR (1) AR039428A1 (pl)
AT (1) ATE271036T1 (pl)
AU (2) AU2003222921A1 (pl)
BR (1) BR0300709A (pl)
CA (1) CA2423825C (pl)
CR (1) CR7576A (pl)
DE (1) DE60300011T2 (pl)
DK (1) DK1354873T3 (pl)
EA (1) EA005676B1 (pl)
EC (1) ECSP045441A (pl)
ES (1) ES2224092T3 (pl)
FR (1) FR2838648B1 (pl)
GE (1) GEP20074211B (pl)
HK (1) HK1057367A1 (pl)
HR (1) HRP20041079B1 (pl)
IL (1) IL164424A (pl)
IS (1) IS2842B (pl)
MA (1) MA27115A1 (pl)
ME (1) ME00454B (pl)
MX (1) MXPA03002346A (pl)
NO (1) NO324323B1 (pl)
NZ (1) NZ524478A (pl)
OA (1) OA12806A (pl)
PL (1) PL359321A1 (pl)
PT (1) PT1354873E (pl)
RS (1) RS51694B (pl)
SI (1) SI1354873T1 (pl)
TN (1) TNSN04206A1 (pl)
TR (1) TR200401793T4 (pl)
UA (1) UA79463C2 (pl)
WO (1) WO2003087050A2 (pl)
ZA (1) ZA200301395B (pl)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2395195A (en) * 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
WO2005094793A1 (en) 2004-03-29 2005-10-13 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for preparing a solid pharmaceutical composition
SI21800A (sl) 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
ATE409036T1 (de) * 2005-01-06 2008-10-15 Ipca Lab Ltd Verfahren zur synthese von (2s,3as,7as)-1-(s)- alanyl-octahydro-1h-2-carbonsäurederivaten und verwendung in der synthese von perindopril
RS51147B (sr) * 2005-03-14 2010-10-31 Les Laboratoires Servier Poboljšani postupak za prečišćavanje perindoprila
FR2894825B1 (fr) * 2005-12-21 2010-12-03 Servier Lab Nouvelle association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion et les compositions pharmaceutiques qui la contiennent
FR2897866B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
SI22542A (sl) * 2007-06-04 2008-12-31 Diagen D.O.O. Stabilna formulacija amorfnih soli perindoprila, postopek za njeno pripravo v industrijskem merilu in njena uporaba za zdravljenje hipertenzije
CA2729604C (en) 2008-06-24 2017-12-05 Matrix Laboratories Ltd. Polymorphic forms of perindopril (l)-arginine and process for the preparation thereof
AU2009212902A1 (en) * 2008-09-03 2010-03-18 Apotex Pharmachem Inc. Amorphous form of an L-arginine salt of perindopril and processes of preparation thereof
CN101766598A (zh) * 2008-12-31 2010-07-07 东英(江苏)药业有限公司 含有培哚普利的药物组合物
GB0910692D0 (en) * 2009-06-20 2009-08-05 Teva Pharma Compound
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
FR2961105B1 (fr) * 2010-06-15 2013-02-08 Servier Lab Utilisation de l'association d'un inhibiteur du courant if sinusal et d'un inhibiteur de l'enzyme de conversion de l'angiotensine pour le traitement de l'insuffisance cardiaque
FR2985512B1 (fr) 2012-01-05 2014-06-20 Servier Lab Procede de preparation du sel de l-arginine du perindopril
FR2985511B1 (fr) 2012-01-05 2014-01-03 Servier Lab Forme cristalline delta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
CN103172696B (zh) * 2012-12-19 2014-12-17 宁波美诺华药业股份有限公司 一种γ晶型的培哚普利精氨酸盐的制备方法
FR3040303B1 (fr) * 2015-08-27 2019-04-05 Les Laboratoires Servier Suivi Par Sabine Goudeau-Wenger Composition pharmaceutique comprenant un inhibiteur de la hmg-coa reductase et un inhibiteur eca
FR3050380B1 (fr) 2016-04-20 2020-07-10 Les Laboratoires Servier Composition pharmaceutique comprenant un betabloquant, un inhibiteur de l'enzyme de conversion et un antihypertenseur ou un ains.
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules
SI26268A (sl) 2021-11-18 2023-05-31 Zupet Rok Postopek za pripravo hidratirane oblike perindopril l-arginina

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2503155A2 (fr) * 1980-10-02 1982-10-08 Science Union & Cie Nouveaux imino diacides substitues, leurs procedes de preparation et leur emploi comme inhibiteur d'enzyme
FR2811320B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Also Published As

Publication number Publication date
NO324323B1 (no) 2007-09-24
ME00454B (me) 2011-10-10
ES2224092T3 (es) 2005-03-01
AU2003222921A1 (en) 2003-10-27
ZA200301395B (en) 2003-09-02
AU2003222921A8 (en) 2003-10-27
GEP20074211B (en) 2007-10-10
OA12806A (en) 2006-07-11
HK1057367A1 (en) 2004-04-02
NO20030849D0 (no) 2003-02-24
AU2003200700B2 (en) 2005-01-20
CA2423825C (fr) 2006-02-21
JP3737488B2 (ja) 2006-01-18
AU2003200700A1 (en) 2003-11-06
CN1451656A (zh) 2003-10-29
US20030199568A1 (en) 2003-10-23
NO20030849L (no) 2003-10-20
SI1354873T1 (en) 2004-12-31
CN1211365C (zh) 2005-07-20
UA79463C2 (en) 2007-06-25
BR0300709A (pt) 2004-09-08
WO2003087050A2 (fr) 2003-10-23
RS90904A (en) 2007-02-05
PT1354873E (pt) 2004-10-29
JP2003321493A (ja) 2003-11-11
MA27115A1 (fr) 2004-12-20
AR039428A1 (es) 2005-02-16
TR200401793T4 (tr) 2004-08-23
US6696481B2 (en) 2004-02-24
WO2003087050A3 (fr) 2004-03-25
DE60300011D1 (de) 2004-08-19
AU2003200700C1 (en) 2015-04-23
KR100542468B1 (ko) 2006-01-11
NZ524478A (en) 2004-05-28
PL359321A1 (pl) 2003-10-20
EP1354873B1 (fr) 2004-07-14
AP1787A (en) 2007-10-04
IL164424A (en) 2010-12-30
EA005676B1 (ru) 2005-04-28
FR2838648B1 (fr) 2004-05-21
IL164424A0 (en) 2005-12-18
EP1354873A1 (fr) 2003-10-22
CR7576A (es) 2008-08-21
MXPA03002346A (es) 2005-08-26
FR2838648A1 (fr) 2003-10-24
CA2423825A1 (fr) 2003-10-18
AP2004003154A0 (en) 2004-12-31
DE60300011T2 (de) 2005-03-17
HRP20041079B1 (hr) 2013-04-30
IS2842B (is) 2013-08-15
EA200300334A1 (ru) 2003-12-25
IS7516A (is) 2004-10-27
ATE271036T1 (de) 2004-07-15
ECSP045441A (es) 2005-03-10
TNSN04206A1 (en) 2007-03-12
KR20030082902A (ko) 2003-10-23
HRP20041079A2 (en) 2004-12-31
RS51694B (en) 2011-10-31

Similar Documents

Publication Publication Date Title
DK1354873T3 (da) Perindoaprilsalt og farmaceutiske sammensætninger indeholdende dette
IS7948A (is) Fosfónóoxýkínasólínafleiður og lyfjafræileg notkun þeirra
NO20054789D0 (no) Sammensetninger inneholdende piperaciliin og tazobactam nytting for injeksjon
PT1501534E (pt) Formulacoes farmaceuticas
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
IS7735A (is) Bensódíasepín afleiður og lyfjasamsetningar sem innihalda þær.
FI20011478A (fi) Farmaseuttinen koostumus
NO20055837D0 (no) Immunsupprimerende forbindelser og sammensetninger
NO20052524D0 (no) Aminerte isofiavonoidderivater og anvendelse derav
PT1467724E (pt) Composicao farmaceutica orodispersavel de agomelatina
IL170313A (en) Diarylcycloalkyl derivatives and pharmaceutical compositions comprising them
DK1425019T3 (da) Farmaceutisk sammensætning omfattende et androgen
DK1458377T3 (da) Farmaceutiske sammensætninger indeholdende tegaserod
DK1635791T3 (da) Farmaceutisk komposition omfattende atorvastatin og fremstillet uden granulering
EE200300589A (et) Ravimkoostised
DE60310914D1 (de) Pulverzusammensetzung
IL176077A0 (en) 1-n-phenyl-amino-1h-imidazole derivatives and pharmaceutical compositions containing them
FI20022128A (fi) Farmaseuttinen koostumus
DK1849468T3 (da) Farmaceutisk sammensætning omfattende roflumilast og levocetirizin
NO20030156D0 (no) Farmasöytiske sammensetninger og fremgangsmåter for anvendelse derav
DK1572950T3 (da) Enkeltdomæne TDF-relaterede forbindelser og analoger deraf
DK1482967T3 (da) Farmaceutiske og kosmetiske sammensætninger omfattende plgf-1
DK1680134T3 (da) Sammensætninger og anvendelser deraf
NO20044164L (no) Farmasoytiske sammensetninger
DE112004001429D2 (de) Pharmazeutischer Wirkstoff